Novel Accelerated Contrast-Enhanced High Resolution Coronary MRI

新型加速对比增强高分辨率冠状动脉 MRI

基本信息

  • 批准号:
    8471770
  • 负责人:
  • 金额:
    $ 10.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is the leading cause of death in the United States, even though significant efforts have been made in prevention and diagnosis. The clinical gold standard for diagnosis of CAD is catheter-based invasive x-ray angiography, performed more than a million times per year. Of these examinations, up to 35% have been found to have no significant stenosis, yet these patients had to go through the potential risks and complications of an invasive test that further exposes the patient to ionizing radiation and iodinated contrast. Thus, non-invasive diagnostic alternatives are highly desirable. Cardiac MRI (CMR) provides a method for comprehensive non-invasive cardiac exam, including contractile functional assessment (cine CMR) to detect wall-motion abnormality, myocardial CMR perfusion for diagnosing perfusion defects, viability assessment using late gadolinium enhancement (LGE) for evaluation of acute and chronic myocardial infarction, and coronary MRI for the identification of stenosis. CMR is advantageous in several respects, since it does not require ionizing radiation or iodinated contrast, thereby facilitating repeated or follow-up scanning. However, long data acquisition time remains as one of its main limitations. Several approaches have been studied to facilitate rapid CMR acquisition. Nonetheless, the acquisition time for high-resolution CMR remains long, and spatial and temporal resolution is traded off for acquisition time in cine and perfusion imaging. Therefore, developments of methods to reduce data acquisition time beyond what is available now are appealing. We will develop novel reconstruction methodologies for high-resolution CMR that learn the anatomical structures in the images being reconstructed. We will validate these techniques in a range of contrast-enhanced CMR imaging protocols, providing better volumetric coverage of the heart, efficient use of the contrast agents, and higher spatial and temporal resolution.
描述(由申请人提供):冠状动脉疾病(CAD)是美国的主要死亡原因,尽管在预防和诊断方面已经做出了重大努力。诊断CAD的临床金标准是基于导管的侵入性X射线血管造影术,每年进行超过一百万次。在这些检查中,高达35%的患者没有发现明显的狭窄,但这些患者必须经历侵入性检查的潜在风险和并发症,进一步使患者暴露于电离辐射和碘造影剂。因此,非侵入性诊断替代方案是高度期望的。 心脏MRI(CMR)提供了一种全面的非侵入性心脏检查方法,包括检测室壁运动异常的收缩功能评估(电影CMR)、诊断灌注缺陷的心肌CMR灌注、使用晚期钆增强(LGE)评价急性和慢性心肌梗死的存活性评估以及用于识别狭窄的冠状动脉MRI。CMR在几个方面是有利的,因为它不需要电离辐射或碘化造影剂,从而便于重复或后续扫描。然而,长的数据采集时间仍然是其主要限制之一。已经研究了几种方法来促进快速CMR采集。尽管如此,高分辨率CMR的采集时间仍然很长,并且在电影和灌注成像中,空间和时间分辨率与采集时间相权衡。因此,开发方法来减少数据采集时间超过现在可用的是有吸引力的。我们将为高分辨率CMR开发新的重建方法,学习正在重建的图像中的解剖结构。我们将在一系列对比增强CMR成像协议中验证这些技术,提供更好的心脏体积覆盖,有效使用造影剂,以及更高的空间和时间分辨率。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sparse Signal Recovery from a Mixture of Linear and Magnitude-Only Measurements.
  • DOI:
    10.1109/lsp.2015.2393295
  • 发表时间:
    2015-09
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Akçakaya M;Tarokh V
  • 通讯作者:
    Tarokh V
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mehmet Akcakaya其他文献

Mehmet Akcakaya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mehmet Akcakaya', 18)}}的其他基金

Robust and Efficient Learning of High-Resolution Brain MRI Reconstruction from Small Referenceless Data
从小型无参考数据中稳健而高效地学习高分辨率脑 MRI 重建
  • 批准号:
    10584324
  • 财政年份:
    2023
  • 资助金额:
    $ 10.2万
  • 项目类别:
Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease
快速综合心脏 MRI 检查诊断冠状动脉疾病
  • 批准号:
    10383694
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease
快速综合心脏 MRI 检查诊断冠状动脉疾病
  • 批准号:
    10171902
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
Novel Quantitative MRI Techniques for the Assessment of Cardiac Fibrosis without Gadolinium Contrast
无需钆对比即可评估心脏纤维化的新型定量 MRI 技术
  • 批准号:
    10319011
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
Novel Quantitative MRI Techniques for the Assessment of Cardiac Fibrosis without Gadolinium Contrast
无需钆对比即可评估心脏纤维化的新型定量 MRI 技术
  • 批准号:
    9977670
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease
快速综合心脏 MRI 检查诊断冠状动脉疾病
  • 批准号:
    10601056
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease
快速综合心脏 MRI 检查诊断冠状动脉疾病
  • 批准号:
    10030978
  • 财政年份:
    2020
  • 资助金额:
    $ 10.2万
  • 项目类别:
TRD3 - Image Reconstruction
TRD3 - 图像重建
  • 批准号:
    10549856
  • 财政年份:
    2019
  • 资助金额:
    $ 10.2万
  • 项目类别:
TRD3 - Image Reconstruction
TRD3 - 图像重建
  • 批准号:
    10376734
  • 财政年份:
    2019
  • 资助金额:
    $ 10.2万
  • 项目类别:
Novel Accelerated Contrast-Enhanced High Resolution Coronary MRI
新型加速对比增强高分辨率冠状动脉 MRI
  • 批准号:
    8224036
  • 财政年份:
    2012
  • 资助金额:
    $ 10.2万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 10.2万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了